Lisanti Capital Growth’s OrthoPediatrics KIDS Stock Holding History

Lisanti Capital Growth’s Portfolio KIDS Stock Details KIDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-119,763	Closed	-$5.53M	–	144
2022 Q3	$5.53M	Sell	119,763 -40,860	-25%	-$2M	0.74%	56
2022 Q2	$6.93M	Buy	160,623 +31,513	+24%	+$1.44M	0.94%	44
2022 Q1	$6.97M	Buy	129,110 +26,165	+25%	+$1.34M	0.78%	53
2021 Q4	$6.16M	Sell	102,945 -480	-0.5%	-$29.9K	0.89%	43
2021 Q3	$6.78M	Buy	103,425 +11,205	+12%	+$728K	1%	33
2021 Q2	$5.83M	Buy	+92,220	New	+$5.3M	0.72%	60
2018 Q1	–	Sell	-28,945	Closed	-$555K	–	124
2017 Q4	$555K	Buy	+28,945	New	+$554K	0.32%	102

Other funds holding KIDS

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lisanti Capital Growth's KIDS Position: Q4 2022 in Review

Lisanti Capital Growth sold out of OrthoPediatrics (KIDS) in Q4 2022, closing a stake of 119,763 shares — an estimated $5.53M sold.

Lisanti Capital Growth first reported a position in KIDS in Q4 2017 and held it in 7 quarters. The position peaked at $6.97M in Q1 2022. 118 funds tracked by Wall St. Rank hold KIDS as of Q4 2022.

Lisanti Capital Growth reported no remaining OrthoPediatrics position as of Q4 2022 after selling out during the quarter.
Lisanti Capital Growth sold 119,763 OrthoPediatrics shares in Q4 2022, an estimated $5.53M.
Lisanti Capital Growth first reported a position in OrthoPediatrics in Q4 2017 and held it in 7 quarters.
Lisanti Capital Growth's OrthoPediatrics position peaked at $6.97M in Q1 2022.
118 funds tracked by Wall St. Rank held OrthoPediatrics as of Q4 2022.

Based on Lisanti Capital Growth's 13F filing for Q4 2022, filed 6 Feb 2023.